DARREN FRED: Open Payments
NPI 1447609052 · FRIENDSWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $73 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $159 |
| Supernus Pharmaceuticals, Inc. | 9 | $149 |
| Otsuka America Pharmaceutical, Inc. | 6 | $134 |
| E.R. Squibb & Sons, L.L.C. | 3 | $75 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
| Tris Pharma Inc | 3 | $58 |
| Lundbeck LLC | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: REXULTI, Auvelity, Qelbree, COBENFY, Dyanavel XR, SPRAVATO, FANAPT, CAPLYTA.
Industry payments across TX — which companies pay providers there.
